IPP Bureau
Caplin Steriles gets US FDA approval for blood pressure injection
By IPP Bureau - September 08, 2021
Labetalol hydrochloride injection USP is indicated for the control of blood pressure in severe hypertension.
Navitas Life Sciences acquires its 200th customer
By IPP Bureau - September 08, 2021
First launched in 2005, pharmaREADY is a fully integrated, regulatory compliant, web-based platform to create, view, and manage global regulatory submissions
Metropolis Healthcare opens a new testing centre in Latur, Maharashtra
By IPP Bureau - September 08, 2021
The lab will offer over 4,000 clinical tests and profiles and can conduct over 20,000 sample tests per month.
Sanofi buys Kadmon to grow its transplant business
By IPP Bureau - September 08, 2021
It adds Rezurock (belumosudil) an FDA-approved, first-in-class treatment for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (cGVHD)
Indian Pharmaceutical Market grew by 17.7 per cent in August
By IPP Bureau - September 07, 2021
Ind-Ra expects IPM revenue to grow over 12% YoY in FY22
Panacea Biotech supplies 1st shipment of the second component of Sputnik V vaccine
By IPP Bureau - September 07, 2021
The batch will be distributed in India through a partner of RDIF and Panacea Biotec - Dr. Reddy's Laboratories
GSK Consumer Health launch first carbon-neutral toothbrush
By IPP Bureau - September 07, 2021
In March it launched its first plastic-free toothbrush packaging, which included Sensodyne Pronamel and parodontax brushes in the US. Asia Pacific rollout of this commenced in Australia
Apollo Hospitals Bangalore first to hit a century of robotic cardiac surgeries
By IPP Bureau - September 07, 2021
In comparison to traditional open-heart surgery, which involves opening up the chest by splitting the breastbone, da Vinci Xi's innovative technology allows for complex cardiovascular surgeries to be performed through smaller incisions and precise motion control
Sharp develops Plasmacluster tech that reduces airborne novel coronavirus
By IPP Bureau - September 07, 2021
Plasmacluster technology significantly inactivates SARS-CoV-2 contained in adherent saliva in an environment with 60% humidity where the physiological protective function is maintained
Healthium Medtech files DRHP for IPO
By IPP Bureau - September 07, 2021
As of FY21, it is the largest independent medical device company and the second-largest company overall, in the surgical consumables market in India with a 7.91 per cent share based on the value
Dr Reddy’s launches Minoxidil for women
By IPP Bureau - September 07, 2021
It is the first-ever approval in India for the treatment of Female Pattern Hair Loss (FPHL) and will be available only on prescription by a dermatologist
ABB’s ACS360 Drives enhance safety and energy efficiency at Bharat Biotech’s Covaxin plant
By IPP Bureau - September 07, 2021
ABB Drives play a key role in the cleanroom infrastructure of Bharat Biotech, India’s first indigenous Covid-19 vaccine manufacturer. The drives are easy to commission, use and ensure higher energy efficiency
HUL funds study on Covid-19 vulnerability and vaccine efficiency
By IPP Bureau - September 07, 2021
The study is being carried out by the platform VISION (Vaccine Immunology Studies – Indian Outbreak-response Network) which includes top public and private research institutes.
Max Ventilator forms partnership with US-based Amptron Medical
By IPP Bureau - September 07, 2021
Amptron’s R &D is based out of the US and this will enable Max to obtain US and other global certifications. Max will retain the right to market, sell and distribute the products in India.
Anti-dumping duty proposed on Vitamin C from China for five years
By IPP Bureau - September 07, 2021
The DGTR has recommended US $ 3.2 per kg and US $ 3.55 per kg duty on imports
